Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine

Data on the efficacy of three SARS-CoV-2 mRNA BNT162b2 vaccine doses and the role of previous SARS-CoV-2-infection in enhancing vaccine immunogenicity in HIV-vertically-infected people living with HIV (PLWH) are limited, as is the duration of vaccine-induced responses. SARS-CoV-2 plasma neutralizing...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in immunology Vol. 14; p. 1301766
Main Authors:	Vanetti, Claudia, Stracuzzi, Marta, Crivellaro, Elisa, Ciciliano, Federica, Garziano, Micaela, Fenizia, Claudio, Biasin, Mara, Rubinacci, Valeria, Amendola, Antonella, Tanzi, Elisabetta, Zuccotti, Gian Vincenzo, Clerici, Mario, Giacomet, Vania, Trabattoni, Daria
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media SA 2023 Frontiers Media S.A
Subjects:	Adult Antiretroviral therapy BNT162 Vaccine CD4 antigen CD8 antigen Cell-mediated immunity COVID-19 - prevention & control COVID-19 SIV individuals COVID-19 Vaccines Enrollments HIV HIV Infections Human immunodeficiency virus Humans Immune response Immune response (cell-mediated) Immune response (humoral) Immunity (Disease) Immunity, Cellular immunocompromised subjects Immunogenicity Immunological memory Immunology Lymphocytes T Memory cells mRNA Observational studies Peptides Plasma PLWH RNA, Messenger SARS-CoV-2 SARS-CoV-2 vaccine efficacy Severe acute respiratory syndrome coronavirus 2 Vaccines Viral infections Viremia γ-Interferon United States > US Italy Germany PLWH immunocompromised subjects immune response COVID-19 SIV individuals SARS-CoV-2 vaccine efficacy
ISSN:	1664-3224, 1664-3224
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!